Amgen Drug Reduces Lung Cancer Tumors In Half Of The Patients!
Posted by
www.biotecnika.org
Amgen Drug Reduces Tumor An experimental drug from Amgen Inc that
targets a specific genetic mutation reduced tumor size in around half
of advanced lung cancer patients, Amgen Inc said in a report. The Drug
is called AMG510. Out of the 13 lung cancer patients taking a 960-mg
dose of AMG510, seven had tumors shrink […]
The post Amgen Drug Reduces Lung Cancer Tumors In Half Of The
Patients! appeared first on BioTecNika .
https://www.biotecnika.org/2019/09/amgen-drug-reduces-lung-cancer-tumors-in-half-of-the-patients/
Biotech News
Subscribe to:
Post Comments (Atom)
Post a Comment